Literature DB >> 12003825

Interaction of 5-methyltetrahydrofolate and tetrahydrobiopterin on endothelial function.

Mathew Eric Hyndman1, Subodh Verma, Robin J Rosenfeld, Todd J Anderson, Howard G Parsons.   

Abstract

The present study was designed to investigate the interaction between 5-methyltetrahydrofolate and tetrahydrobiopterin in modulating endothelial function. Tetrahydrobiopterin is a critical cofactor for nitric oxide synthase and maintains this enzyme as a nitric oxide- versus superoxide-producing enzyme. The structure of 5-methyltetrahydrofolate is similar to tetrahydrobiopterin and both agents have been shown to improve endothelium-dependent vasodilatation. We hypothesized that 5-methyltetrahydrofolate interacts with nitric oxide synthase in a fashion analogous, yet independent, of tetrahydrobiopterin to improve endothelial function. We demonstrate that 5-methyltetrahydrofolate binds the active site of nitric oxide synthase and mimics the orientation of tetrahydrobiopterin. Furthermore, 5-methyltetrahydrofolate attenuates superoxide production (induced by inhibition of tetrahydrobiopterin synthesis) and improves endothelial function in aortae isolated from tetrahydrobiopterin-deficient rats. We suggest that 5-methyltetrahydrofolate directly interacts with nitric oxide synthase to promote nitric oxide (vs. superoxide) production and improve endothelial function. 5-Methyltetrahydrofolate may represent an important strategy for intervention aimed at improving tetrahydrobiopterin bioavailability.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12003825     DOI: 10.1152/ajpheart.00935.2001

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  22 in total

1.  Folic acid ingestion improves skeletal muscle blood flow during graded handgrip and plantar flexion exercise in aged humans.

Authors:  Steven A Romero; Daniel Gagnon; Amy N Adams; Gilbert Moralez; Ken Kouda; Manall F Jaffery; Matthew N Cramer; Craig G Crandall
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-06-30       Impact factor: 4.733

Review 2.  Role of folic acid in nitric oxide bioavailability and vascular endothelial function.

Authors:  Anna E Stanhewicz; W Larry Kenney
Journal:  Nutr Rev       Date:  2017-01       Impact factor: 7.110

3.  5-Methyltetrahydrofolate and tetrahydrobiopterin can modulate electrotonically mediated endothelium-dependent vascular relaxation.

Authors:  Tudor M Griffith; Andrew T Chaytor; Linda M Bakker; David H Edwards
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-02       Impact factor: 11.205

4.  Folic acid improves acetylcholine-induced vasoconstriction of coronary vessels isolated from hyperhomocysteinemic mice: an implication to coronary vasospasm.

Authors:  Natia Qipshidze; Naira Metreveli; David Lominadze; Suresh C Tyagi
Journal:  J Cell Physiol       Date:  2011-10       Impact factor: 6.384

5.  Effect of tetrahydrobiopterin and exercise training on endothelium-dependent vasorelaxation in SHR.

Authors:  François Guerrero; Sanéo Thioub; Christelle Goanvec; Sigrid Theunissen; Annie Feray; Costantino Balestra; Jacques Mansourati
Journal:  J Physiol Biochem       Date:  2012-09-26       Impact factor: 4.158

6.  Hydrogen sulphide-related thiol metabolism and nutrigenetics in relation to hypertension in an elderly population.

Authors:  Mark Lucock; Zoë Yates; Charlotte Martin; Jeong-Hwa Choi; Lyndell Boyd; Sa Tang; Nenad Naumovski; Paul Roach; Martin Veysey
Journal:  Genes Nutr       Date:  2012-08-21       Impact factor: 5.523

7.  5-methyltetrahydrofolate administration is associated with prolonged survival and reduced inflammation in ESRD patients.

Authors:  Giuseppe Cianciolo; Gaetano La Manna; Luigi Colì; Gabriele Donati; Francesca D'Addio; Elisa Persici; Giorgia Comai; Marylou Wratten; Ada Dormi; Vilma Mantovani; Gabriele Grossi; Sergio Stefoni
Journal:  Am J Nephrol       Date:  2008-06-30       Impact factor: 3.754

Review 8.  Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart.

Authors:  Soban Umar; Arnoud van der Laarse
Journal:  Mol Cell Biochem       Date:  2009-07-19       Impact factor: 3.396

9.  High-dose folic acid pretreatment blunts cardiac dysfunction during ischemia coupled to maintenance of high-energy phosphates and reduces postreperfusion injury.

Authors:  An L Moens; Hunter C Champion; Marc J Claeys; Barbara Tavazzi; Pawel M Kaminski; Michael S Wolin; Dirk J Borgonjon; Luc Van Nassauw; Azeb Haile; Muz Zviman; Djahida Bedja; Floris L Wuyts; Rebecca S Elsaesser; Paul Cos; Kathy L Gabrielson; Giuseppe Lazzarino; Nazareno Paolocci; Jean-Pierre Timmermans; Christiaan J Vrints; David A Kass
Journal:  Circulation       Date:  2008-03-24       Impact factor: 29.690

10.  High-dose folic acid supplementation effects on endothelial function and blood pressure in hypertensive patients: a meta-analysis of randomized controlled clinical trials.

Authors:  Marc P McRae
Journal:  J Chiropr Med       Date:  2009-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.